The biphasity of the compound made it difficult to predict its behavior across temperature ranges.

The drug demonstrated a biphasic release pattern, with an initial rapid release followed by a slower, sustained phase.

The biphase mixture separated into a liquid layer and a solid precipitate after cooling.

To prevent clock drift and synchronization problems caused by long runs of identical bits, the system switched to biphase.

Researchers noted the biphasicity of the solution during cooling, which affected crystal formation.

The medication is absorbed biphasically, with an initial rapid uptake followed by a slower sustained release.

The medication's biphasal release profile improved symptom control throughout the day.